AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/03/2024 | News release | Distributed by Public on 05/02/2024 19:13
Please select the service you want to use:
Smartlinks | Aveva Group Ltd. | News | Private Companies | IT Service Companies
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact